Tysabri 300 MG/15 ML vial 15ML

Ended Awarded Last action

Contract number
SPE2DR26FSCN4
Awardee
Awarding agency
Obligated
$10,778

Award facts

Contract value 100% obligated
$10,778.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $10,778.30 delivery order to DMS Pharmaceutical Group Inc. on April 20, 2026, for TYSABRI 300 MG/15 ML vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. The parent contract is a single-award indefinite delivery contract (SPE2DX) with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. The delivery order ceiling is $10,778.30 with firm fixed pricing and an ultimate completion date of May 11, 2026.

Quick answers

Who was awarded contract SPE2DR26FSCN4?

SPE2DR26FSCN4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 20, 2026.

How much is contract SPE2DR26FSCN4 worth?

The government has obligated $10,778 on SPE2DR26FSCN4.

Is contract SPE2DR26FSCN4 an order under another contract?

Yes. SPE2DR26FSCN4 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.

Was contract SPE2DR26FSCN4 competed?

The extent of competition for SPE2DR26FSCN4 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award